Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2020 Jun 29;8(1):e000845corr1. doi: 10.1136/jitc-2019-000845corr1

Correction: 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo

PMCID: PMC7326241  PMID: 32601080

Baroni ML, Sanchez Martinez D, Gutierrez Aguera F, et al. 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo. J Immunother Cancer 2020;8:e000845. doi: 10.1136/jitc-2020-000845

Since the online publication of this article, it was noticed that 'Samanta Romina Zanetti' was incorrectly spelt as 'Samanta Zanetti'. This error has been corrected.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES